EODData

MEMBERSHIP REGISTER LOG IN

FRA, UR8: UroGen Pharma Ltd

10 Nov 2025
LAST:

19.70

CHANGE:
 0.20		OPEN:
19.70		HIGH:
19.70		ASK:
0.00		VOLUME:
0
CHG(%):
1.03		PREV:
19.50		LOW:
19.70		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Nov 2519.7019.7019.7019.700
07 Nov 2519.5019.5019.5019.500
06 Nov 2516.4016.4015.0015.000
05 Nov 2516.9016.9016.9016.9050
04 Nov 2517.4017.4017.4017.4050
03 Nov 2517.3017.3017.3017.300
31 Oct 2516.9016.9016.9016.900
30 Oct 2516.7017.1016.7017.100
29 Oct 2517.0017.0017.0017.000
28 Oct 2517.6017.6017.6017.600

COMPANY PROFILE

Name:UroGen Pharma Ltd
About:UroGen Pharma Ltd. engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; and Jelmyto for pyelocalyceal solution. The company's lead product candidate are UGN-102 for pyelocalyceal solution; UGN-103, which is in phase 3 of clinical trial for intravesical solution; and UGN-104 that is in phase 3 of clinical trial for pyelocalyceal solution designed for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer (NMIBC). It is also developing UGN-301, UGN-301+ UGN 201, and UGN-301+gemcitabine that are in phase 1 of clinical trial for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 and UGN-104. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:400 Alexander Park Drive, Princeton, NJ, United States, 08540
Website:https://www.urogen.com
ISIN:IL0011407140

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-5.88 
Forward P/E:-4.71 
PEG Ratio:-0.38 
Price to Sales:8.89 
Price to Book:-17.88 
Profit Margin:-1.64 
Operating Margin:-1.71 
Return on Assets:-0.31 
Return on Equity:14.41 
Revenue:81.79M 
Shares:46.26M 
Market Cap:911.4M 

TECHNICAL INDICATORS

MA5:17.7011.3%
MA10:17.4413.0%
MA20:16.0622.7%
MA50:15.6525.9%
MA100:14.9232.0%
MA200:11.8366.5%
STO9:100.00 
STO14:100.00 
RSI14:68.55 
MTM14:4.40
ROC14:0.29 
ATR:0.91 
Week High:19.700.0%
Week Low:15.0031.3%
Month High:19.700.0%
Month Low:13.8066.5%
Year High:19.700.0%
Year Low:3.30496.2%
Volatility:51.00